Methods of treating prostate cancer

TW202637173APending Publication Date: 2026-09-16ASTRAZENECA AB
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114145469
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-09-05
Filing Date
2025-11-21
Publication Date
2026-09-16

Smart Images

  • Figure TWG2TA001076474_001
    Figure TWG2TA001076474_001
  • Figure TWG2TA001076474_002
    Figure TWG2TA001076474_002
  • Figure TWG2TA001076474_003
    Figure TWG2TA001076474_003
Patent Text Reader

Abstract

The present disclosure relates to methods of treating PTEN-deficient metastatic hormone-sensitive prostate cancer (mHSPC) in patients in need thereof, the methods comprising administering to the patients a combination comprising capivasertib or a pharmaceutically acceptable salt thereof; and abiraterone or an ester prodrug thereof, or a pharmaceutically acceptable salt thereof.
Need to check novelty before this filing date? Find Prior Art